Clinical Trial Update: PK/PD Study of YZJ-1139 [Phase 1]

View source ↗

Summary

A Phase 1 PK/PD study of YZJ-1139 for insomnia has completed, providing initial pharmacokinetic and pharmacodynamic data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• YZJ-1139

Snippet

Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Conditions: Insomnia | Phase 1 | Status: COMPLETED